Cargando…

Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring

SIMPLE SUMMARY: In this review, we discuss the possible advantages and methods to overcome potential obstacles of applying combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beuthien-Baumann, Bettina, Sachpekidis, Christos, Gnirs, Regula, Sedlaczek, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657132/ https://www.ncbi.nlm.nih.gov/pubmed/34885129 http://dx.doi.org/10.3390/cancers13236019

Ejemplares similares

Hybrid imaging with [(68)Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
por: Glemser, P. A., et al.
Publicado: (2022)

PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical Problems
por: Schuler, Markus K., et al.
Publicado: (2013)

PET/MRI in head and neck cancer: initial experience
por: Platzek, Ivan, et al.
Publicado: (2012)

Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT
por: Alberts, Ian, et al.
Publicado: (2021)

Quantitative, Dynamic (18)F-FDG PET/CT in Monitoring of Smoldering Myeloma: A Case Report
por: Sachpekidis, Christos, et al.
Publicado: (2021)

Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2017)

Can physiologic colonic [(18)F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
por: Sachpekidis, Christos, et al.
Publicado: (2023)

Assessment of early metabolic progression in melanoma patients under immunotherapy: an (18)F-FDG PET/CT study
por: Sachpekidis, Christos, et al.
Publicado: (2021)

The prognostic value of [(18)F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria
por: Sachpekidis, Christos, et al.
Publicado: (2023)

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Long axial field of view (LAFOV) PET-CT: implementation in static and dynamic oncological studies
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2023)

CT, MRI and PET imaging in peritoneal malignancy
por: Patel, Chirag M., et al.
Publicado: (2011)

Imaging of COVID-19: CT, MRI, and PET
por: Fields, Brandon K.K., et al.
Publicado: (2021)

Fractal and multifractal analysis of PET/CT images of metastatic melanoma before and after treatment with ipilimumab
por: Breki, Christina-Marina, et al.
Publicado: (2016)

The influence of digital PET/CT on diagnostic certainty and interrater reliability in [(68)Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer
por: Alberts, Ian, et al.
Publicado: (2021)

PET/CT and PET/MRI in ophthalmic oncology (Review)
por: Kalemaki, Maria S., et al.
Publicado: (2020)

Suitability of bilateral filtering for edge-preserving noise reduction in PET
por: Hofheinz, Frank, et al.
Publicado: (2011)

Comparison of functional imaging in multiple myeloma patients: Indication for hybrid-imaging with PET/MRI?
por: Mosebach, J, et al.
Publicado: (2015)

PET/MRI and PET/CT hybrid imaging of rectal cancer – description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study
por: Rutegård, Miriam K., et al.
Publicado: (2019)

PET and PET/CT imaging of skeletal metastases
por: Cook, Gary J.R.
Publicado: (2010)

Hybrid imaging with PET/CT and PET/MR
por: Kjaer, Andreas
Publicado: (2014)

Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer
por: Ming, Yue, et al.
Publicado: (2020)

A method for model-free partial volume correction in oncological PET
por: Hofheinz, Frank, et al.
Publicado: (2012)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Liver cancer imaging: role of CT, MRI, US and PET
por: Oliva, Maria Raquel, et al.
Publicado: (2004)

Functional Imaging with (18)F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient
por: Sachpekidis, Christos, et al.
Publicado: (2017)

Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer
por: Liu, Yi, et al.
Publicado: (2019)

Aortic valve stenosis—multimodality assessment with PET/CT and PET/MRI
por: Tzolos, Evangelos, et al.
Publicado: (2020)

PET/CT and the Response to Immunotherapy in Lung Cancer
por: Evangelista, Laura, et al.
Publicado: (2020)

Clinical molecular anatomic imaging: PET, PET/CT, and Spect/CT
por: Von Schulthess, Gustav K
Publicado: (2003)

PET/MR for therapy response evaluation in malignant lymphoma: initial experience
por: Platzek, Ivan, et al.
Publicado: (2012)

Correction of scan time dependence of standard uptake values in oncological PET
por: van den Hoff, Jörg, et al.
Publicado: (2014)

Image quality and detectability in Siemens Biograph PET/MRI and PET/CT systems—a phantom study
por: Øen, Silje Kjærnes, et al.
Publicado: (2019)

Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
por: Scobioala, Sergiu, et al.
Publicado: (2021)

Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT: A systematic review protocol
por: Shao, Hongsheng, et al.
Publicado: (2018)

Application of the long axial field-of-view PET/CT with low-dose [(18)F]FDG in melanoma
por: Sachpekidis, Christos, et al.
Publicado: (2022)

Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2020)

Conspicuity of Malignant Lesions on PET/CT and Simultaneous Time-Of-Flight PET/MRI
por: Minamimoto, Ryogo, et al.
Publicado: (2017)

Characterization of multiple myeloma osseous lesions and diffuse infiltration pattern by 18F-FDG-PET/CT, static MRI and diffusion-weighted MR Imaging (DWI-MRI): a comparative multimodality imaging study
por: Mosebach, J, et al.
Publicado: (2014)

Comparison of (68)Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer
por: Regula, Naresh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8tak750of7291h8s2dnp8jud5a